Rani Therapeutics Holdings Inc (NASDAQ: RANI) on Friday, plunged -8.09% from the previous trading day, before settling in for the closing price of $1.36. Within the past 52 weeks, RANI’s price has moved between $1.30 and $8.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 83.82%. The company achieved an average annual earnings per share of 7.89%. With a float of $22.81 million, this company’s outstanding shares have now reached $29.81 million.
Let’s determine the extent of company efficiency that accounts for 140 employees. In terms of profitability, gross margin is 73.45%, operating margin of -1883.31%, and the pretax margin is -1996.98%.
Rani Therapeutics Holdings Inc (RANI) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rani Therapeutics Holdings Inc is 31.51%, while institutional ownership is 14.32%. The most recent insider transaction that took place on Dec 13 ’24, was worth 29,993. In this transaction Chief Business Officer of this company bought 17,960 shares at a rate of $1.67, taking the stock ownership to the 17,960 shares. Before that another transaction happened on Dec 09 ’24, when Company’s Chief Executive Officer bought 10,296 for $1.94, making the entire transaction worth $19,974. This insider now owns 494,751 shares in total.
Rani Therapeutics Holdings Inc (RANI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.89% per share during the next fiscal year.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Rani Therapeutics Holdings Inc (RANI) is currently performing well based on its current performance indicators. A quick ratio of 1.60 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Looking closely at Rani Therapeutics Holdings Inc (NASDAQ: RANI), its last 5-days average volume was 0.42 million, which is a jump from its year-to-date volume of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 15.19%. Additionally, its Average True Range was 0.14.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.15% in the past 14 days, which was lower than the 125.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8996, while its 200-day Moving Average is $3.3107. However, in the short run, Rani Therapeutics Holdings Inc’s stock first resistance to watch stands at $1.3433. Second resistance stands at $1.4367. The third major resistance level sits at $1.4833. If the price goes on to break the first support level at $1.2033, it is likely to go to the next support level at $1.1567. Should the price break the second support level, the third support level stands at $1.0633.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
Market capitalization of the company is 71.78 million based on 57,289K outstanding shares. Right now, sales total 0 K and income totals -33,970 K. The company made 0 K in profit during its latest quarter, and -6,780 K in sales during its previous quarter.
